CD8A and neoplasm: In addition to the early modification of the tumor microenvironment, our data showed that at later stages of tumor response, high-dose Lipo-MP-LPS, but not low-dose, induces a massive recruitment of M1 macrophages and activated CD8 T-cells in tumors.